A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma

NCT07527169 PHASE2 NOT_YET_RECRUITING

The goal of this clinical research study is to learn if zanzalintinib can help to control recurrent/metastatic ONB. The safety of zanzalintinib will also be studied.

Details

Lead sponsor	M.D. Anderson Cancer Center
Phase	PHASE2
Status	NOT_YET_RECRUITING
Enrolment	16
Start date	Thu Oct 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Metastatic Olfactory Neuroblastoma

Interventions

• Zanzalintinib

Countries

United States